Inhibition of GPX4 enhances CDK4/6 inhibitor activity in breast cancer

被引：0
|
作者：
Abreu, Maria Teresa Herrera
Khalid, Uzma
Ning, Jian
Cutts, Rosalind
Wilson, Gemma
Lord, Christopher
Swain, Amanda
Turner, Nicholas
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS12-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS12-04
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer
    Dang, Fabin
    Nie, Li
    Zhou, Jin
    Shimizu, Kouhei
    Chu, Chen
    Wu, Zhong
    Fassl, Anne
    Ke, Shizhong
    Wang, Yuangao
    Zhang, Jinfang
    Zhang, Tao
    Tu, Zhenbo
    Inuzuka, Hiroyuki
    Sicinski, Piotr
    Bass, Adam J.
    Wei, Wenyi
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [22] Pfizer's CDK4/6 inhibitor approved for advanced breast cancer
    Morrison, Chris
    NATURE BIOTECHNOLOGY, 2015, 33 (04) : 323 - 324
  • [23] Breast cancer: CDK4/6 inhibitor plus fulvestrant prolongs survival
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (02)
  • [24] Pfizer's CDK4/6 inhibitor approved for advanced breast cancer
    Chris Morrison
    Nature Biotechnology, 2015, 33 : 323 - 324
  • [25] The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
    Schoninger, Scott F.
    Blain, Stacy W.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 3 - 12
  • [26] CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer
    Zhang, Kai
    Hong, Ruoxi
    Kaping, Lee
    Xu, Fei
    Xia, Wen
    Qin, Ge
    Zheng, Qiufan
    Lu, Qianyi
    Zhai, Qinglian
    Shi, Yanxia
    Yuan, Zhongyu
    Deng, Wuguo
    Chen, Miao
    Wang, Shusen
    CANCER LETTERS, 2019, 447 : 130 - 140
  • [27] CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure
    Garrido-Castro A.C.
    Goel S.
    Current Breast Cancer Reports, 2017, 9 (1) : 26 - 33
  • [28] CDK4/6 inhibition in early stage triple negative breast cancer
    Kietzman, William B.
    Ory, Virginie
    Saenz, Fransisco
    Sharif, Ghada
    Wellstein, Anton
    Riegel, Anna T.
    CANCER RESEARCH, 2017, 77
  • [29] Mechanisms of resistance to CDK4/6 inhibition in ER plus breast cancer
    Lee, N. V.
    Eisele, K. J.
    Chionis, J.
    Yuan, J.
    Zhu, Z.
    Liu, C.
    Li, D.
    Olson, P. A.
    Fantin, V.
    Arndt, K. T.
    Shields, D. J.
    VanArsdale, T. L.
    CANCER RESEARCH, 2016, 76
  • [30] CDK4/6 INHIBITION IN BREAST CANCER: THE LATE HARVEST CYCLE BEGINS
    Goel, Shom
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 96 - 96
12345